argus

SMS Pharmaceuticals Ltd

NSE: SMSPHARMAINE812G010253,494 Cr

Timeline

Time (IST)TypeMEventSrc
15 May, 04:48 pmMonitoring Agency Report for the quarter ended 31st March, 2026nse
15 May, 04:46 pmSMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Monitoring Agency Reportbse
30 Apr, 04:15 pmSMS Pharmaceuticals Limited has informed the Exchange about General Updatesnse
30 Apr, 03:49 pmSMS Pharmaceuticals Ltd - 532815 - Confirmation Of Not- Falling Under 'Large Corporate' Criteriabse
29 Apr, 12:03 pmSMS Pharmaceuticals Ltd - 532815 - Receipt Of Rectification Order By Income Tax Departmentbse
29 Apr, 12:01 pmSMS Pharmaceuticals Limited has informed the Exchange about Action(s) taken or orders passednse
31 Mar, 07:06 pmSMS Pharmaceuticals Ltd - 532815 - Demand Notice From Income Tax Departmentbse
31 Mar, 07:01 pmSMS Pharmaceuticals Limited has informed the Exchange about Action(s) initiated or orders passednse
10 Feb, 06:35 pmMonitoring Agency Report for 31st December, 2025nse
10 Feb, 06:31 pmSMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Monitoring Agency Reportbse
09 Feb, 07:23 pmSMS Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 09, 2026, titled "Press release on Financial Results".nse
09 Feb, 07:23 pmSMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
09 Feb, 07:19 pmSMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
09 Feb, 07:18 pmSMS Pharmaceuticals Limited has informed the Exchange about Investor Presentationnse
07 Feb, 04:56 pmSMS Pharmaceuticals Ltd - 532815 - Statement Of Deviation Or Variation For The Quarter Ended December 31, 2025bse
07 Feb, 04:52 pmSMS Pharmaceuticals Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32nse
07 Feb, 04:43 pmSMS Pharmaceuticals Ltd - 532815 - Financial Results For The Quarter Ended 31St December, 2025bse
07 Feb, 04:40 pmFinancial resultsnse
07 Feb, 04:34 pmSMS Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.nse
31 Jan, 05:35 pmSMS Pharmaceuticals Ltd - 532815 - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended 31St December, 2025bse
17 Jan, 03:25 pmSMS Pharmaceuticals Limited has informed the Exchange regarding 'Report on transfer requests of physical shares re-lodged under the special window'.nse
26 Dec, 06:40 pmSMS Pharmaceuticals Limited has informed the Exchange about Investments in Subsidiary Company by way of subscription towards Rights Issuense
24 Dec, 11:51 amSMS Pharmaceuticals Limited has informed the Exchange about Incorporation of wholly owned subsidiary companynse
24 Dec, 11:46 amSMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Acquisitionbse
12 Dec, 08:00 pmSMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
12 Dec, 07:58 pmSMS Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 12, 2025, titled "Completion of USFDA inspection at Vizag manufacturing facility".nse
04 Dec, 09:58 amSMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Credit Ratingbse
04 Dec, 09:58 amSMS Pharmaceuticals Limited has informed the Exchange about Credit Ratingnse
26 Nov, 08:22 amSMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
26 Nov, 08:22 amSMS Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 26, 2025, titled "Press Release".nse
13 Nov, 06:25 pmSMS Pharmaceuticals Limited has informed the Exchange about Transcriptnse
13 Nov, 06:19 pmSMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
12 Nov, 06:32 pmMonitoring Agency Report for the quarter ended 30th September, 2025nse
12 Nov, 06:31 pmSMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Monitoring Agency Reportbse
11 Nov, 05:06 pmSMS Pharmaceuticals Ltd - 532815 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
11 Nov, 03:40 pmSMS Pharmaceuticals Ltd - 532815 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
11 Nov, 02:49 pmSMS Pharmaceuticals Limited has informed the Exchange about Link of Recordingnse
11 Nov, 02:49 pmSMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
10 Nov, 06:42 pmSMS Pharmaceuticals Limited has informed the Exchange about Investor Presentationnse
10 Nov, 06:41 pmSMS Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 10, 2025, titled "Press release on financial results".nse
10 Nov, 06:15 pmSMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
10 Nov, 06:13 pmSMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
08 Nov, 02:31 pmSMS Pharmaceuticals Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32nse
08 Nov, 02:26 pmSMS Pharmaceuticals Ltd - 532815 - Statement Of Deviation Or Variation For The Quarter Ended September 30, 2025bse
08 Nov, 02:10 pmFinancial results for the quarter ended 30th September, 2025nse
08 Nov, 02:06 pmSMS Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.nse
08 Nov, 02:01 pmSMS Pharmaceuticals Ltd - 532815 - Board Meeting Outcome for Outcome Of Board Meeting For Financial Resultsbse
07 Nov, 03:24 pmSMS Pharmaceuticals Limited has informed the Exchange regarding 'receipt of trading approval from stock exchanges'.nse
06 Nov, 10:55 amSMS Pharmaceuticals Ltd - 532815 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011bse
06 Nov, 09:25 amSMS Pharmaceuticals Ltd - 532815 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011bse